Avery Dennison Corp 10-Q for FY2022 Q3
Avery Dennison Corp (AVY)
10-Q
2022-11-01
For: 2022-10-01
View Original
Added on
April 09, 2026
About this 10-Q
Avery Dennison Corp filed this 10-Q on November 1, 2022, covering the quarter ended October 1, 2022 (FY2022 Q3).
Headline figures
Quarter ended October 1, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $2.32B
- up 11.8% from $2.07B a year earlier
- Net income
- $221.5M
- up 35.0% from net income of $164.1M a year earlier
- Diluted EPS
- $2.70
- up 37.8% from $1.96 a year earlier
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 10-Q
(Mark One)
| QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | |||||
For the quarterly period ended October 1, 2022 .
OR
| TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | |||||
For the transition period from ________________________ to ________________________
Commission file number 1-7685
(Exact name of registrant as specified in its charter)
| (State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) | |||||||
| (Address of Principal Executive Offices) | (Zip Code) | |||||||
Registrant’s telephone number, including area code: (440 ) 534-6000
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||||||||
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes x No o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
x | o Accelerated filer | o Non-accelerated filer | ||||||||||||||||||||||||
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No x
Number of shares of $1 par value common stock outstanding as of October 29, 2022: 80,969,014
AVERY DENNISON CORPORATION
FISCAL THIRD QUARTER 2022 QUARTERLY REPORT ON FORM 10-Q
TABLE OF CONTENTS
| Page | ||||||||
| Exhibits | ||||||||
Safe Harbor Statement
The matters discussed in this Quarterly Report contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These statements, which are not statements of historical fact, contain estimates, assumptions, projections and/or expectations regarding future events, that may or may not occur. Words such as “aim,” “anticipate,” “assume,” “believe,” “continue,” “could,” “estimate,” “expect,” “foresee,” “guidance,” “intend,” “may,” “might,” “objective,” “plan,” “potential,” “project,” “seek,” “shall,” “should,” “target,” “will,” “would,” or variations thereof, and other expressions that refer to future events and trends, identify forward-looking statements. These forward-looking statements, and financial or other business targets, are subject to certain risks and uncertainties.
We believe that the most significant risk factors that could affect our financial performance in the near term include: (i) the impacts to underlying demand for our products from global economic conditions, political uncertainty, and changes in environmental standards and governmental regulations, including as a result of COVID-19; (ii) the cost and availability of raw materials; (iii) competitors’ actions, including pricing, expansion in key markets, and product offerings; (iv) the degree to which higher costs can be offset with productivity measures and/or passed on to customers through price increases, without a significant loss of volume; (v) foreign currency fluctuations; and (vi) the execution and integration of acquisitions.
The more significant risks and uncertainties that may impact us are discussed in more detail under “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our 2021 Annual Report on Form 10-K filed on February 23, 2022, and subsequent quarterly reports on Form 10-Q. Actual results and trends may differ materially from historical or anticipated results depending on a variety of factors, including but not limited to, risks and uncertainties related to the following:
•Our Business – fluctuations in demand affecting sales to customers; fluctuations in the cost and availability of raw materials and energy; changes in our markets due to competitive conditions, technological developments, environmental standards, laws and regulations, and customer preferences; the impact of competitive products and pricing; execution and integration of acquisitions; selling prices; customer and supplier concentrations or consolidations; financial condition of distributors; outsourced manufacturers; product and service quality; timely development and market acceptance of new products, including sustainable or sustainably-sourced products; investment in development activities and new production facilities; successful implementation of new manufacturing technologies and installation of manufacturing equipment; our ability to generate sustained productivity improvement; our ability to achieve and sustain targeted cost reductions; and collection of receivables from customers
•International Operations – worldwide and local economic and market conditions; changes in political conditions, including those related to the Russian invasion of Ukraine; and fluctuations in foreign currency exchange rates and other risks associated with foreign operations, including in emerging markets
•COVID-19
•Income Taxes – fluctuations in tax rates; changes in tax laws and regulations, and uncertainties associated with interpretations of such laws and regulations; retention of tax incentives; outcome of tax audits; and the realization of deferred tax assets
•Information Technology – disruptions in information technology systems or data security breaches, including cyber-attacks or other intrusions to network security; and successful installation of new or upgraded information technology systems
•Human Capital – recruitment and retention of employees; and collective labor arrangements
•Our Indebtedness – credit risks; our ability to obtain adequate financing arrangements and maintain access to capital; fluctuations in interest rates; volatility of financial markets; and compliance with our debt covenants
•Ownership of Our Stock – potential significant variability of our stock price and amounts of future dividends and share repurchases
•Legal and Regulatory Matters – protection and infringement of intellectual property; impact of legal and regulatory proceedings, including with respect to environmental, anti-corruption, health and safety, and trade compliance
•Other Financial Matters – fluctuations in pension costs and goodwill impairment
Our forward-looking statements are made only as of the date of this Form 10-Q. We assume no duty to update these forward-looking statements to reflect new, changed or unanticipated events or circumstances, other than as may be required by law.
1
Avery Dennison Corporation
PART I. FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited)
| (Dollars in millions, except per share amount) | October 1, 2022 | January 1, 2022 | |||||||||
| Assets | |||||||||||
| Current assets: | |||||||||||
| Cash and cash equivalents | $ | $ | |||||||||
Trade accounts receivable, less allowances of $ | |||||||||||
| Inventories | |||||||||||
| Other current assets | |||||||||||
| Total current assets | |||||||||||
| Property, plant and equipment, net | |||||||||||
| Goodwill | |||||||||||
| Other intangibles resulting from business acquisitions, net | |||||||||||
| Deferred tax assets | |||||||||||
| Other assets | |||||||||||
| $ | $ | ||||||||||
| Liabilities and Shareholders’ Equity | |||||||||||
| Current liabilities: | |||||||||||
| Short-term borrowings and current portion of long-term debt and finance leases | $ | $ | |||||||||
| Accounts payable | |||||||||||
| Accrued payroll and employee benefits | |||||||||||
| Other current liabilities | |||||||||||
| Total current liabilities | |||||||||||
| Long-term debt and finance leases | |||||||||||
| Long-term retirement benefits and other liabilities | |||||||||||
| Deferred tax liabilities and income taxes payable | |||||||||||
| Commitments and contingencies (see Note 11) | |||||||||||
| Shareholders’ equity: | |||||||||||
Common stock, $ | |||||||||||
| Capital in excess of par value | |||||||||||
| Retained earnings | |||||||||||
Treasury stock at cost, | ( | ( | |||||||||
| Accumulated other comprehensive loss | ( | ( | |||||||||
| Total shareholders’ equity | |||||||||||
| $ | $ | ||||||||||
See Notes to Unaudited Condensed Consolidated Financial Statements
2
Avery Dennison Corporation
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(Unaudited)
| Three Months Ended | Nine Months Ended | ||||||||||||||||||||||
| (In millions, except per share amounts) | October 1, 2022 | October 2, 2021 | October 1, 2022 | October 2, 2021 | |||||||||||||||||||
| Net sales | $ | $ | $ | $ | |||||||||||||||||||
| Cost of products sold | |||||||||||||||||||||||
| Gross profit | |||||||||||||||||||||||
| Marketing, general and administrative expense | |||||||||||||||||||||||
| Other expense (income), net | ( | ( | |||||||||||||||||||||
| Interest expense | |||||||||||||||||||||||
| Other non-operating expense (income), net | ( | ( | ( | ( | |||||||||||||||||||
| Income before taxes | |||||||||||||||||||||||
| Provision for income taxes | |||||||||||||||||||||||
| Equity method investment (losses) gains | ( | ( | |||||||||||||||||||||
| Net income | $ | $ | $ | $ | |||||||||||||||||||
| Per share amounts: | |||||||||||||||||||||||
| Net income per common share | $ | $ | $ | $ | |||||||||||||||||||
| Net income per common share, assuming dilution | $ | $ | $ | $ | |||||||||||||||||||
| Weighted average number of shares outstanding: | |||||||||||||||||||||||
| Common shares | |||||||||||||||||||||||
| Common shares, assuming dilution | |||||||||||||||||||||||
See Notes to Unaudited Condensed Consolidated Financial Statements
3
Avery Dennison Corporation
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(Unaudited)
| Three Months Ended | Nine Months Ended | ||||||||||||||||||||||
| (In millions) | October 1, 2022 | October 2, 2021 | October 1, 2022 | October 2, 2021 | |||||||||||||||||||
| Net income | $ | $ | $ | $ | |||||||||||||||||||
| Other comprehensive income (loss), net of tax: | |||||||||||||||||||||||
| Foreign currency translation | ( | ( | |||||||||||||||||||||
| Pension and other postretirement benefits | |||||||||||||||||||||||
| Cash flow hedges | |||||||||||||||||||||||
| Other comprehensive income (loss), net of tax | ( | ( | |||||||||||||||||||||
| Total comprehensive income, net of tax | $ | $ | $ | $ | |||||||||||||||||||
See Notes to Unaudited Condensed Consolidated Financial Statements
4
Avery Dennison Corporation
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
| Nine Months Ended | |||||||||||
| (In millions) | October 1, 2022 | October 2, 2021 | |||||||||
| Operating Activities | |||||||||||
| Net income | $ | $ | |||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||||
| Depreciation | |||||||||||
| Amortization | |||||||||||
| Provision for credit losses and sales returns | |||||||||||
| Stock-based compensation | |||||||||||
| Pension plan settlement loss | |||||||||||
| Deferred taxes and other non-cash taxes | ( | ( | |||||||||
| Other non-cash expense and loss (income and gain), net | |||||||||||
| Changes in assets and liabilities and other adjustments | ( | ( | |||||||||
| Net cash provided by operating activities | |||||||||||
| Investing Activities | |||||||||||
| Purchases of property, plant and equipment | ( | ( | |||||||||
| Purchases of software and other deferred charges | ( | ( | |||||||||
| Proceeds from sales of property, plant and equipment | |||||||||||
| Proceeds from insurance and sales (purchases) of investments, net | |||||||||||
| Proceeds from sale of product line | |||||||||||
| Payments for acquisitions, net of cash acquired, and investments in businesses | ( | ( | |||||||||
| Net cash used in investing activities | ( | ( | |||||||||
| Financing Activities | |||||||||||
| Net increase (decrease) in borrowings with maturities of three months or less | |||||||||||
| Additional long-term borrowings | |||||||||||
| Repayments of long-term debt and finance leases | ( | ( | |||||||||
| Dividends paid | ( | ( | |||||||||
| Share repurchases | ( | ( | |||||||||
| Net (tax withholding) proceeds related to stock-based compensation | ( | ( | |||||||||
Net cash (used in) provided by financing activities | ( | ||||||||||
| Effect of foreign currency translation on cash balances | ( | ( | |||||||||
| Increase (decrease) in cash and cash equivalents | ( | ( | |||||||||
| Cash and cash equivalents, beginning of year | |||||||||||
| Cash and cash equivalents, end of period | $ | $ | |||||||||
See Notes to Unaudited Condensed Consolidated Financial Statements
5
Avery Dennison Corporation
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
Note 1. General
The unaudited Condensed Consolidated Financial Statements and related notes in this Quarterly Report on Form 10-Q are presented as permitted by Article 10 of Regulation S-X and do not contain certain information included in the audited Consolidated Financial Statements and related notes in our 2021 Annual Report on Form 10-K, which should be read in conjunction with this Quarterly Report on Form 10-Q. These unaudited Condensed Consolidated Financial Statements contain all adjustments of a normal and recurring nature necessary for a fair statement of our interim results. Interim results of operations are not necessarily indicative of future results. These unaudited Condensed Consolidated Financial Statements reflect our current estimates and assumptions affecting (i) our reported amounts of assets and liabilities and related disclosures as of the date of the financial statements and (ii) our reported amounts of sales and expenses during the reporting periods presented.
Fiscal Periods
The three and nine months ended October 1, 2022 and October 2, 2021 each consisted of thirteen-week and thirty-nine week periods, respectively.
Note 2. Acquisitions
2022 Acquisitions
During January 2022, we completed our acquisitions of TexTrace AG ("TexTrace"), a Switzerland-based technology developer specializing in custom-made woven and knitted radio-frequency identification ("RFID") products that can be sewn onto or inserted into garments, and Rietveld Serigrafie B.V. and Rietveld Screenprinting Serigrafi Baski Matbaa Tekstil Ithalat Ihracat Sanayi ve Ticaret Limited Sirketi (collectively, "Rietveld"), a Netherlands-based provider of external embellishment solutions and application and printing methods for performance brands and team sports in Europe. These acquisitions expand the product portfolio in our Retail Branding and Information Solutions ("RBIS") reportable segment. The acquisitions of TexTrace and Rietveld are referred to collectively as the "2022 Acquisitions."
The aggregate purchase consideration for the 2022 Acquisitions was approximately $35 million. We funded the 2022 Acquisitions using cash and commercial paper borrowings. In addition to the cash paid at closing, the sellers in one of these acquisitions are eligible for earn-out payments of up to $30 million, subject to the acquired company achieving certain post-acquisition performance targets. As of the acquisition date, we included an estimate of the fair value of these earn-out payments in the aggregate purchase consideration.
The 2022 Acquisitions were not material, individually or in the aggregate, to the unaudited Condensed Consolidated Financial Statements.
Vestcom Acquisition
On August 31, 2021, we completed our acquisition of CB Velocity Holdings, LLC (“Vestcom”), an Arkansas-based provider of shelf-edge pricing, productivity and consumer engagement solutions for retailers and consumer packaged goods companies, for purchase consideration of $1.47 billion. We funded this acquisition using a combination of cash and proceeds from commercial paper borrowings and issuances of senior notes. Refer to Note 4, "Debt," to the unaudited Condensed Consolidated Financial Statements for more information.
We believe Vestcom’s solutions expand our position in high value categories and add channel access and data management capabilities to our RBIS reportable segment.
6
Avery Dennison Corporation
The table below summarizes the fair values of assets acquired and liabilities assumed in the Vestcom acquisition based on our final allocation of the purchase consideration.
| (In millions) | ||||||||
| Cash and cash equivalents | $ | |||||||
| Trade accounts receivable | ||||||||
| Other current assets | ||||||||
| Property, plant and equipment | ||||||||
| Goodwill | ||||||||
| Other intangibles resulting from business acquisition | ||||||||
| Other assets | ||||||||
| Total assets | ||||||||
| Current liabilities | ||||||||
| Other liabilities | ||||||||
| Deferred and non-current income taxes liabilities | ||||||||
| Total liabilities | ||||||||
| Net assets acquired | $ | |||||||
The impact of the Vestcom acquisition was not material to the pro forma net sales or net income of our combined operations for the periods presented. Net sales and net income related to Vestcom post-acquisition were not material to the unaudited Condensed Consolidated Statements of Income for three and nine months ended October 2, 2021.
Note 3. Goodwill and Other Intangibles Resulting from Business Acquisitions
The goodwill from the 2022 Acquisitions was not material to the unaudited Condensed Consolidated Financial Statements. Refer to Note 2, "Acquisitions," to the unaudited Condensed Consolidated Financial Statements for more information.
Changes in the net carrying amount of goodwill for the nine months ended October 1, 2022 by reportable segment are shown below.
| (In millions) | Label and Graphic Materials | Retail Branding and Information Solutions | Industrial and Healthcare Materials | Total | |||||||||||||||||||
Goodwill as of January 1, 2022 | $ | $ | $ | $ | |||||||||||||||||||
Acquisitions(1) | |||||||||||||||||||||||
Acquisition adjustment(2) | ( | ( | |||||||||||||||||||||
| Translation adjustments | ( | ( | ( | ( | |||||||||||||||||||
Goodwill as of October 1, 2022 | $ | $ | $ | $ | |||||||||||||||||||
(1)Goodwill acquired related to the 2022 Acquisitions. We expect the recognized goodwill related to the 2022 Acquisitions to be no n-deductible for income tax purposes.
(2)Measurement period adjustment related to the finalization of the purchase price allocation for the August 2021 acquisition of Vestcom.
In connection with the 2022 Acquisitions, we acquired approximately $21 million of identifiable finite-lived intangible assets, which consisted of patented and other developed technology as well as customer relationships.
Amortization expense for all finite-lived intangible assets resulting from business acquisitions was $20.4 million and $11.7 million for the three months ended October 1, 2022 and October 2, 2021, respectively, and $61.5 million and $24.6 million for the nine months ended October 1, 2022 and October 2, 2021, respectively.
7
Avery Dennison Corporation
Estimated future amortization expense related to existing finite-lived intangible assets for the remainder of fiscal year 2022 and for each of the next four fiscal years is shown below. These amounts include the effects of the 2022 Acquisitions and updated amounts from year-end 2021.
| Estimated Amortization Expense | |||||
| 2022 (remainder of year) | $ | ||||
| 2023 | |||||
| 2024 | |||||
| 2025 | |||||
| 2026 | |||||
Note 4. Debt
In August 2021, we issued $500 million of senior notes, due February 15, 2032, which bear an interest rate of 2.250 %, payable semiannually in arrears. Our net proceeds from this issuance, after deducting underwriting discounts and offering expenses, were $493.8 million. Additionally, in August 2021, we issued $300 million of senior notes, due August 15, 2024, which we can repay without penalty and bear an interest rate of 0.850 %, payable semiannually in arrears. Our net proceeds from this issuance, after deducting underwriting discounts and offering expenses, were $298.1 million. We used the net proceeds from these two debt issuances to finance a portion of the Vestcom acquisition.
The estimated fair value of our long-term debt is primarily based on the credit spread above U.S. Treasury securities or euro government bond securities, as applicable, on notes with similar rates, credit ratings and remaining maturities. The fair value of short-term borrowings, which include commercial paper issuances and short-term lines of credit, approximates their carrying value given the short duration of these obligations. The fair value of our total debt was $2.83 billion at October 1, 2022 and $3.25 billion at January 1, 2022. Fair values were determined based primarily on Level 2 inputs, which are inputs other than quoted prices in active markets that are either directly or indirectly observable.
Our $800 million revolving credit facility (the “Revolver”) contains a financial covenant requiring that we maintain a specified ratio of total debt in relation to a certain measure of income. As of both October 1, 2022 and January 1, 2022, we were in compliance with this financial covenant. No
Note 5. Cost Reduction Actions
Note 6. Financial Instruments
We enter into foreign exchange hedge contracts to reduce our risk from foreign exchange rate fluctuations associated with receivables, payables, loans and firm commitments denominated in certain foreign currencies that arise primarily as a result of our operations outside the U.S. We also enter into futures contracts to hedge certain price fluctuations for a portion of our anticipated domestic purchases of natural gas. The impact of these foreign exchange and commodities hedge activities on the unaudited Condensed Consolidated Financial Statements was not material.
In March 2020, we entered into U.S. dollar to euro cross-currency swap contracts with a total notional amount of $250 million to have the effect of converting the fixed-rate U.S. dollar-denominated debt to euro-denominated debt, including semiannual interest payments and the payment of principal at maturity. During the term of the contract, which ends on April 30, 2030, we pay fixed-rate interest in euros and receive fixed-rate interest in U.S. dollars. These contracts have been designated as cash flow hedges. The fair value of these contracts was $29.8 million as of October 1, 2022, which was included in "Other Assets" and $(10.3 ) million as of January 1, 2022, which was included in “Long-term retirement benefits and other liabilities” in the unaudited Condensed Consolidated Balance Sheets. Refer to Note 10, “Fair Value Measurements,” to the unaudited Condensed Consolidated Financial Statements for more information.
We recorded no ineffectiveness from our cross-currency swap to earnings during the three or nine months ended October 1, 2022 or October 2, 2021.
8
Avery Dennison Corporation
Note 7. Taxes Based on Income
The following table summarizes our income before taxes, provision for income taxes, and effective tax rate:
| Three Months Ended | Nine Months Ended | ||||||||||||||||||||||
| (Dollars in millions) | October 1, 2022 | October 2, 2021 | October 1, 2022 | October 2, 2021 | |||||||||||||||||||
| Income before taxes | $ | $ | $ | $ | |||||||||||||||||||
| Provision for income taxes | |||||||||||||||||||||||
| Effective tax rate | % | % | % | % | |||||||||||||||||||
Our provision for income taxes for the three and nine months ended October 1, 2022 included $2.8 million and $16.5 million, respectively, of net tax charge related to the tax on global intangible low-taxed income (“GILTI”) of our foreign subsidiaries and the recognition of foreign withholding taxes on current year earnings, partially offset by the benefit from foreign-derived intangible income (“FDII”). Our provision for income taxes for the three and nine months ended October 1, 2022 also included the following discrete items: (i) $17.3 11.9 6.4 million of net discrete tax benefit primarily from decreases in certain tax reserves, including interest and penalties, as a result of closing tax years.
Our provision for income taxes for the three and nine months ended October 2, 2021 included $7 million and $21 million, respectively, of net tax charge related to the tax on GILTI of our foreign subsidiaries and the recognition of foreign withholding taxes on current year earnings, partially offset by the benefit from FDII. Our provision for income taxes for the three and nine months ended October 2, 2021 also included $11.3 8.7 14.1 million of return-to-provision benefit related to a GILTI exclusion election made on our amended 2018 U.S. federal tax return.
In 2020, the U.S. Department of Treasury issued final regulations that provide certain U.S. taxpayers with an annual election to exclude certain foreign income subject to a high effective tax rate from their GILTI inclusions. We have not yet determined whether to make the election for tax year 2022. We continue to evaluate the impact of the election and currently anticipate that the benefit from making this election on our 2022 U.S. federal tax return may be significant.
The amount of income taxes we pay is subject to ongoing audits by taxing jurisdictions around the world. Our estimate of the potential outcome of any uncertain tax issue is subject to our assessment of the relevant risks, facts, and circumstances existing at the time. We believe that we have adequately provided for reasonably foreseeable outcomes related to these matters. However, our future results may include favorable or unfavorable adjustments to our estimated tax liabilities in the period the assessments are made or resolved, which may impact our effective tax rate. The final determination of tax audits and any related legal proceedings could materially differ from the amounts currently reflected in our tax provision for income taxes and the related liabilities. To date, we and our U.S. subsidiaries have completed the Internal Revenue Service ("IRS") Compliance Assurance Process through 2018. With limited exceptions, we are no longer subject to income tax examinations by tax authorities for years prior to 2010.
It is reasonably possible that, during the next 12 months, we may realize a net decrease in our uncertain tax positions, including interest and penalties, of approximately $5 million, primarily as a result of closing tax years.
9
Avery Dennison Corporation
Note 8. Net Income Per Common Share
Net income per common share was computed as follows:
| Three Months Ended | Nine Months Ended | ||||||||||||||||||||||
| (In millions, except per share amounts) | October 1, 2022 | October 2, 2021 | October 1, 2022 | October 2, 2021 | |||||||||||||||||||
(A)Net income | $ | $ | $ | $ | |||||||||||||||||||
(B)Weighted average number of common shares outstanding | |||||||||||||||||||||||
Dilutive shares (additional common shares issuable under stock-based awards) | |||||||||||||||||||||||
(C) Weighted average number of common shares outstanding, assuming dilution | |||||||||||||||||||||||
| Net income per common share: (A) ÷ (B) | $ | $ | $ | $ | |||||||||||||||||||
| Net income per common share, assuming dilution: (A) ÷ (C) | $ | $ | $ | $ | |||||||||||||||||||
Certain stock-based compensation awards were excluded from the computation of net income per common share, assuming dilution, because they would not have had a dilutive effect. Stock-based compensation awards excluded from the computation were not significant for the three or nine months ended October 1, 2022 or October 2, 2021.
Note 9. Supplemental Equity and Comprehensive Income Information
Consolidated Changes in Shareholders’ Equity
| Three Months Ended | Nine Months Ended | ||||||||||||||||||||||
| (In millions) | October 1, 2022 | October 2, 2021 | October 1, 2022 | October 2, 2021 | |||||||||||||||||||
Common stock issued, $ | $ | $ | $ | $ | |||||||||||||||||||
| Capital in excess of par value | |||||||||||||||||||||||
| Beginning balance | $ | $ | $ | $ | |||||||||||||||||||
Issuance of shares under stock-based compensation plans(1) | ( | ||||||||||||||||||||||
| Ending balance | $ | $ | $ | $ | |||||||||||||||||||
| Retained earnings | |||||||||||||||||||||||
| Beginning balance | $ | $ | $ | $ | |||||||||||||||||||
| Net income | |||||||||||||||||||||||
Issuance of shares under stock-based compensation plans(1) | ( | ( | |||||||||||||||||||||
Contribution of shares to 401(k) plan(1) | |||||||||||||||||||||||
| Dividends | ( | ( | ( | ( | |||||||||||||||||||
| Ending balance | $ | $ | $ | $ | |||||||||||||||||||
| Treasury stock at cost | |||||||||||||||||||||||
| Beginning balance | $ | ( | $ | ( | $ | ( | $ | ( | |||||||||||||||
| Repurchase of shares for treasury | ( | ( | ( | ( | |||||||||||||||||||
Issuance of shares under stock-based compensation plans(1) | |||||||||||||||||||||||
Contribution of shares to 401(k) plan(1) | |||||||||||||||||||||||
| Ending balance | $ | ( | $ | ( | $ | ( | $ | ( | |||||||||||||||
| Accumulated other comprehensive loss | |||||||||||||||||||||||
| Beginning balance | $ | ( | $ | ( | $ | ( | $ | ( | |||||||||||||||
| Other comprehensive income (loss), net of tax | ( | ( | |||||||||||||||||||||
| Ending balance | $ | ( | $ | ( | $ | ( | $ | ( | |||||||||||||||
10
Avery Dennison Corporation
Dividends per common share were as follows:
| Three Months Ended | Nine Months Ended | ||||||||||||||||||||||
| October 1, 2022 | October 2, 2021 | October 1, 2022 | October 2, 2021 | ||||||||||||||||||||
| Dividends per common share | $ | $ | $ | $ | |||||||||||||||||||
In April 2022, our Board authorized the repurchase of shares of our common stock with a fair market value of up to $750 million, excluding any fees, commissions or other expenses related to such purchases and in addition to the amount outstanding under our previous Board authorization. Board authorizations remain in effect until shares in the amount authorized thereunder have been repurchased. As of October 1, 2022, shares of our common stock in the aggregate amount of $791 million remained authorized for repurchase under our outstanding Board authorizations.
Changes in Accumulated Other Comprehensive Loss
The changes in “Accumulated other comprehensive loss” (net of tax) for the nine-month period ended October 1, 2022 were as follows:
| (In millions) | Foreign Currency Translation | Pension and Other Postretirement Benefits | Cash Flow Hedges | Total | |||||||||||||||||||
Balance as of January 1, 2022 | $ | ( | $ | ( | $ | ( | $ | ( | |||||||||||||||
| Other comprehensive income (loss) before reclassifications, net of tax | ( | ( | |||||||||||||||||||||
| Reclassifications to net income, net of tax | ( | ||||||||||||||||||||||
| Other comprehensive income (loss), net of tax | ( | ( | |||||||||||||||||||||
Balance as of October 1, 2022 | $ | ( | $ | ( | $ | ( | $ | ( | |||||||||||||||
The changes in “Accumulated other comprehensive loss” (net of tax) for the nine-month period ended October 2, 2021 were as follows:
| (In millions) | Foreign Currency Translation | Pension and Other Postretirement Benefits | Cash Flow Hedges | Total | |||||||||||||||||||
Balance as of January 2, 2021 | $ | ( | $ | ( | $ | ( | $ | ( | |||||||||||||||
| Other comprehensive income (loss) before reclassifications, net of tax | |||||||||||||||||||||||
| Reclassifications to net income, net of tax | ( | ||||||||||||||||||||||
| Other comprehensive income (loss), net of tax | |||||||||||||||||||||||
Balance as of October 2, 2021 | $ | ( | $ | ( | $ | ( | $ | ( | |||||||||||||||
11
Avery Dennison Corporation
Note 10. Fair Value Measurements
Recurring Fair Value Measurements
Assets and liabilities carried at fair value, measured on a recurring basis, as of October 1, 2022 were as follows:
| Fair Value Measurements Using | |||||||||||||||||||||||
| (In millions) | Total | Quoted Prices in Active Markets (Level 1) | Significant Other Observable Inputs (Level 2) | Significant Other Unobservable Inputs (Level 3) | |||||||||||||||||||
| Assets | |||||||||||||||||||||||
| Investments | $ | $ | $ | $ | |||||||||||||||||||
| Derivative assets | |||||||||||||||||||||||
| Bank drafts | |||||||||||||||||||||||
| Cross-currency swap | |||||||||||||||||||||||
| Liabilities | |||||||||||||||||||||||
| Derivative liabilities | $ | $ | $ | $ | |||||||||||||||||||
| Contingent consideration liabilities | |||||||||||||||||||||||
Assets and liabilities carried at fair value, measured on a recurring basis, as of January 1, 2022 were as follows:
| Fair Value Measurements Using | |||||||||||||||||||||||
| (In millions) | Total | Quoted Prices in Active Markets (Level 1) | Significant Other Observable Inputs (Level 2) | Significant Other Unobservable Inputs (Level 3) | |||||||||||||||||||
| Assets | |||||||||||||||||||||||
| Investments | $ | $ | $ | $ | |||||||||||||||||||
| Derivative assets | |||||||||||||||||||||||
| Bank drafts | |||||||||||||||||||||||
| Liabilities | |||||||||||||||||||||||
| Cross-currency swap | $ | $ | $ | $ | |||||||||||||||||||
| Derivative liabilities | |||||||||||||||||||||||
| Contingent consideration liabilities | |||||||||||||||||||||||
Investments include fixed income securities (primarily U.S. government and corporate debt securities) measured at fair value using quoted prices/bids and a money market fund measured at fair value using net asset value. As of October 1, 2022, investments of $0.8 million and $29.8 million were included in “Cash and cash equivalents” and “Other current assets,” respectively, in the unaudited Condensed Consolidated Balance Sheets. As of January 1, 2022, investments of $0.5 million and $33.4 million were included in “Cash and cash equivalents” and “Other current assets,” respectively, in the unaudited Condensed Consolidated Balance Sheets. Derivatives that are exchange-traded are measured at fair value using quoted market prices and classified within Level 1 of the valuation hierarchy. Derivatives measured based on foreign exchange rate inputs that are readily available in public markets are classified within Level 2 of the valuation hierarchy. Bank drafts (maturities greater than three months) are valued at face value due to their short-term nature and were included in “Other current assets” in the unaudited Condensed Consolidated Balance Sheets.
Contingent consideration liabilities relate to estimated earn-out payments associated with certain acquisitions completed in 2022 and 2021, which are subject to the respective acquired company achieving certain post-acquisition performance targets. These liabilities were recorded based on the expected payments as of October 1, 2022 and have been classified as Level 3.
In addition to the items described above, we also have made venture investments in privately held companies and utilize the measurement alternative for equity investments that do not have readily determinable fair values, measuring them at cost less impairment plus or minus observable price changes in orderly transactions. We recognized net gains on these investments of $8.7 million and $12.4 million in the three and nine months ended October 1, 2022, respectively, and $4.9 64 million and $52 million as of October 1, 2022 and January 1, 2022, respectively, and included in “Other assets” in the unaudited Condensed Consolidated Balance Sheets.
12
Avery Dennison Corporation
Note 11. Commitments and Contingencies
Legal Proceedings
We are involved in various lawsuits, claims, inquiries, and other regulatory and compliance matters, most of which are routine to the nature of our business. When it is probable that a loss will be incurred and where a range of the loss can be reasonably estimated, the best estimate within the range is accrued. When the best estimate within the range cannot be determined, the low end of the range is accrued. The ultimate resolution of these claims could affect future results of operations should our exposure be materially different from our estimates or should we incur liabilities that were not previously accrued. Potential insurance reimbursements are not offset against potential liabilities.
We are currently party to a litigation in which ADASA Inc. (“Adasa”), an unrelated third party, alleged that certain of our RFID products infringed on its patent. We recorded a contingent liability related to this matter in the second quarter of 2021 in the amount of $26.6 million based on a jury verdict issued on May 14, 2021. During the third quarter of 2021, the first instance judgment associated with the jury verdict was issued. This resulted in additional potential liability of $35.8 million for, among other things, royalties on a higher number of tags and royalties on tags sold after March 31, 2021. We have not increased our previously recorded contingent liability for this additional potential liability. With continued evaluation of the matter and our defenses, as well as consultation with our outside counsel, we continue to believe that Adasa’s patent is invalid and that, even if valid, we have not infringed it, and that the royalty rate used as the basis for the jury’s determination is unreasonable under prevailing industry standards, as well as that any liability related to this matter would be substantially lower than that which is reflected in either the jury verdict or the first instance judgment. On October 22, 2021, we appealed the judgment to the United States Court of Appeals for the Federal Circuit and continue to believe meritorious defenses exist to significantly reduce the liability we currently have recorded. The oral hearing was held on September 8, 2022, and the court has yet to issue a decision. As our appeal is still pending, we maintained our current contingent liability of $26.6 million for this matter as a reasonable estimate within the range of probable outcomes. We have largely completed our migration to alternative encoding methods used in our other RFID tags.
Because of the uncertainties associated with claims resolution and litigation, future expenses to resolve these matters could be higher than the liabilities we have accrued; however, we are unable to reasonably estimate a range of potential expenses. If information were to become available that allowed us to reasonably estimate a range of potential expenses in an amount higher or lower than what we have accrued and determined such to be probable, we would adjust our accrued liabilities accordingly. Additional lawsuits, claims, inquiries, and other regulatory and compliance matters could arise in the future. The range of expenses for resolving any future matters would be assessed as they arise; until then, a range of potential expenses for such resolution cannot be determined. Based upon current information, we believe that the impact of the resolution of these matters would not be, individually or in the aggregate, material to our financial position, results of operations or cash flows.
Environmental Expenditures
Environmental expenditures are generally expensed. When it is probable that a loss will be incurred and where a range of the loss can be reasonably estimated, the best estimate within the range is accrued. When the best estimate within the range cannot be determined, the low end of the range is accrued. The ultimate resolution of these matters could affect future results of operations should our exposure be materially different from our estimates or should we incur liabilities that were not previously accrued. Potential insurance reimbursements are not offset against potential liabilities. We review our estimates of the costs of complying with environmental laws related to remediation and cleanup of various sites, including sites in which governmental agencies have designated us as a potentially responsible party (“PRP”). However, environmental expenditures for newly acquired assets and those that extend or improve the economic useful life of existing assets are capitalized and amortized over the shorter of the estimated useful life of the acquired asset or the remaining life of the existing asset.
As of October 1, 2022, we have been designated by the U.S. Environmental Protection Agency (“EPA”) and/or other responsible state agencies as a PRP at eleven waste disposal or waste recycling sites that are the subject of separate investigations or proceedings concerning alleged soil and/or groundwater contamination. No settlement of our liability related to any of these sites has been agreed upon. We are participating with other PRPs at these sites and anticipate that our share of remediation costs will be determined pursuant to agreements that we negotiate with the EPA or other governmental authorities.
These estimates could change as a result of changes in planned remedial actions, remediation technologies, site conditions, the estimated time to complete remediation, environmental laws and regulations, and other factors. Because of the uncertainties associated with environmental assessment and remediation activities, our future expenses to remediate these sites could be higher than the liabilities we have accrued; however, we are unable to reasonably estimate a range of potential expenses. If information were to become available that allowed us to reasonably estimate a range of potential expenses in an amount higher or lower than what we have accrued, we would adjust our environmental liabilities accordingly. In addition, we may be identified as a PRP at additional sites in the future. The range of expenses for remediation of any future-identified sites would be addressed as they arise; until then, a range of expenses for such remediation cannot be determined.
13
Avery Dennison Corporation
The activity related to our environmental liabilities for the nine months ended October 1, 2022 is shown below.
| (In millions) | |||||
Balance at January 1, 2022 | $ | ||||
| Charges, net of reversals | |||||
| Payments | ( | ||||
Balance at October 1, 2022 | $ | ||||
Note 12. Segment and Disaggregated Revenue Information
Disaggregated Revenue Information
Disaggregated revenue information is shown below in the manner that best reflects how the nature, amount, timing and uncertainty of our revenue and cash flows are affected by economic factors. Revenue from our Label and Graphic Materials reportable segment is attributed to geographic areas based on the location from which products are shipped. Revenue from our RBIS reportable segment is shown by product group.
| Three Months Ended | Nine Months Ended | ||||||||||||||||||||||
| (In millions) | October 1, 2022 | October 2, 2021 | October 1, 2022 | October 2, 2021 | |||||||||||||||||||
| Net sales to unaffiliated customers | |||||||||||||||||||||||
| Label and Graphic Materials: | |||||||||||||||||||||||
| U.S. | $ | $ | $ | $ | |||||||||||||||||||
| Europe | |||||||||||||||||||||||
| Asia | |||||||||||||||||||||||
| Latin America | |||||||||||||||||||||||
| Other international | |||||||||||||||||||||||
| Total Label and Graphic Materials | |||||||||||||||||||||||
| Retail Branding and Information Solutions: | |||||||||||||||||||||||
| Apparel | |||||||||||||||||||||||
| Identification Solutions and Vestcom | |||||||||||||||||||||||
| Total Retail Branding and Information Solutions | |||||||||||||||||||||||
| Industrial and Healthcare Materials | |||||||||||||||||||||||
| Net sales to unaffiliated customers | $ | $ | $ | $ | |||||||||||||||||||
14
Avery Dennison Corporation
Additional Segment Information
Additional financial information by reportable segment and Corporate is shown below.
| Three Months Ended | Nine Months Ended | ||||||||||||||||||||||
| (In millions) | October 1, 2022 | October 2, 2021 | October 1, 2022 | October 2, 2021 | |||||||||||||||||||
| Intersegment sales | |||||||||||||||||||||||
| Label and Graphic Materials | $ | $ | $ | $ | |||||||||||||||||||
| Retail Branding and Information Solutions | |||||||||||||||||||||||
| Industrial and Healthcare Materials | |||||||||||||||||||||||
| Intersegment sales | $ | $ | $ | $ | |||||||||||||||||||
| Income before taxes | |||||||||||||||||||||||
| Label and Graphic Materials | $ | $ | $ | $ | |||||||||||||||||||
| Retail Branding and Information Solutions | |||||||||||||||||||||||
| Industrial and Healthcare Materials | |||||||||||||||||||||||
| Corporate expense | ( | ( | ( | ( | |||||||||||||||||||
| Interest expense | ( | ( | ( | ( | |||||||||||||||||||
| Other non-operating expense (income), net | |||||||||||||||||||||||
| Income before taxes | $ | $ | $ | $ | |||||||||||||||||||
| Other expense (income), net, by reportable segment and Corporate | |||||||||||||||||||||||
| Label and Graphic Materials | $ | ( | $ | $ | ( | $ | ( | ||||||||||||||||
| Retail Branding and Information Solutions | |||||||||||||||||||||||
| Industrial and Healthcare Materials | |||||||||||||||||||||||
| Corporate | |||||||||||||||||||||||
| Other expense (income), net | $ | ( | $ | $ | ( | $ | |||||||||||||||||
Other expense (income), net, by type was as follows:
| Three Months Ended | Nine Months Ended | ||||||||||||||||||||||
| (In millions) | October 1, 2022 | October 2, 2021 | October 1, 2022 | October 2, 2021 | |||||||||||||||||||
| Other expense (income), net, by type | |||||||||||||||||||||||
| Restructuring charges: | |||||||||||||||||||||||
| Severance and related costs | $ | $ | $ | $ | |||||||||||||||||||
| Asset impairment charges and lease cancellation costs | |||||||||||||||||||||||
| Other items: | |||||||||||||||||||||||
| Transaction and related costs | |||||||||||||||||||||||
Outcomes of legal proceedings, net(1) | ( | ||||||||||||||||||||||
| Gain on venture investments | ( | ( | ( | ( | |||||||||||||||||||
| (Gain) loss on sales of assets, net | ( | ||||||||||||||||||||||
| Gain on sale of product line | ( | ( | |||||||||||||||||||||
| Other expense (income), net | $ | ( | $ | $ | ( | $ | |||||||||||||||||
(1) Amount for the first nine months of 2021 includes an indirect tax credit based on a Brazilian Supreme Federal Court ruling in the amount of $ | |||||||||||||||||||||||
15
Avery Dennison Corporation
Note 13. Supplemental Financial Information
Inventories
The table below summarizes amounts in inventories.
| (In millions) | October 1, 2022 | January 1, 2022 | |||||||||
| Raw materials | $ | $ | |||||||||
| Work-in-progress | |||||||||||
| Finished goods | |||||||||||
| Inventories | $ | $ | |||||||||
Property, Plant and Equipment, Net
The table below summarizes the amounts in property, plant and equipment, net.
| (In millions) | October 1, 2022 | January 1, 2022 | |||||||||
| Property, plant and equipment | $ | $ | |||||||||
| Accumulated depreciation | ( | ( | |||||||||
| Property, plant and equipment, net | $ | $ | |||||||||
Allowance for Credit Losses
| Nine Months Ended | |||||||||||
| (In millions) | October 1, 2022 | October 2, 2021 | |||||||||
| Beginning balance | $ | $ | |||||||||
Provision for (reversal of) credit losses | ( | ||||||||||
| Amounts written off | ( | ( | |||||||||
| Other, including foreign currency translation | ( | ||||||||||
| Ending balance | $ | $ | |||||||||
Note 14. Recent Accounting Requirements
16
Avery Dennison Corporation
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Management’s Discussion and Analysis of Financial Condition and Results of Operations, or MD&A, provides management’s views on our financial condition and results of operations and should be read in conjunction with the accompanying unaudited Condensed Consolidated Financial Statements and related notes.
NON-GAAP FINANCIAL MEASURES
We report our financial results in conformity with accounting principles generally accepted in the United States of America, or GAAP, and also communicate with investors using certain non-GAAP financial measures. These non-GAAP financial measures are not in accordance with, nor are they a substitute for or superior to, the comparable GAAP financial measures. These non-GAAP financial measures are intended to supplement the presentation of our financial results prepared in accordance with GAAP. Based on feedback from investors and financial analysts, we believe that the supplemental non-GAAP financial measures we provide are useful to their assessments of our performance and operating trends, as well as liquidity.
Our non-GAAP financial measures exclude the impact of certain events, activities or strategic decisions. The accounting effects of these events, activities or decisions, which are included in the GAAP financial measures, may make it more difficult to assess our underlying performance in a single period. By excluding the accounting effects, positive or negative, of certain items (e.g., restructuring charges, outcomes of certain legal proceedings, certain effects of strategic transactions and related costs, losses from debt extinguishments, gains or losses from curtailment or settlement of pension obligations, gains or losses on sales of certain assets, gains or losses on venture investments and other items), we believe that we are providing meaningful supplemental information that facilitates an understanding of our core operating results and liquidity measures. While some of the items we exclude from GAAP financial measures recur, they tend to be disparate in amount, frequency or timing.
We use these non-GAAP financial measures internally to evaluate trends in our underlying performance, as well as to facilitate comparison to the results of competitors for quarters and year-to-date periods, as applicable.
We use the non-GAAP financial measures described below in this MD&A.
•Sales change ex. currency refers to the increase or decrease in net sales, excluding the estimated impact of foreign currency translation and the reclassification of sales between segments, and, where applicable, an extra week in our fiscal year and the calendar shift resulting from the extra week in the prior fiscal year, and currency adjustment for transitional reporting of highly inflationary economies. The estimated impact of foreign currency translation is calculated on a constant currency basis, with prior period results translated at current period average exchange rates to exclude the effect of currency fluctuations.
•Organic sales change refers to sales change ex. currency, excluding the estimated impact of acquisitions and product line divestitures.
We believe that sales change ex. currency and organic sales change assist investors in evaluating the sales change from the ongoing activities of our businesses and enhance their ability to evaluate our results from period to period.
•Free cash flow refers to cash flow provided by operating activities, less payments for property, plant and equipment, software and other deferred charges, plus proceeds from sales of property, plant and equipment, plus (minus) net proceeds from insurance and sales (purchases) of investments. Free cash flow is also adjusted for, where applicable, certain acquisition-related transaction costs. We believe that free cash flow assists investors by showing the amount of cash we have available for debt reductions, dividends, share repurchases and acquisitions.
•Operational working capital as a percentage of annualized current quarter net sales refers to trade accounts receivable and inventories, net of accounts payable, and excludes cash and cash equivalents, short-term borrowings, deferred taxes, other current assets and other current liabilities, as well as net current assets or liabilities held-for-sale divided by annualized current quarter net sales. We believe that operational working capital as a percentage of annualized current quarter net sales assists investors in assessing our working capital requirements because it excludes the impact of fluctuations attributable to our financing and other activities (which affect cash and cash equivalents, deferred taxes, other current assets and other current liabilities) that tend to be disparate in amount, frequency or timing, and may increase the volatility of working capital as a percentage of sales from period to period. The items excluded from this measure are not significantly influenced by our day-to-day activities managed at the operating level and do not necessarily reflect the underlying trends in our operations.
17
Avery Dennison Corporation
OVERVIEW AND OUTLOOK
Net Sales
The factors impacting reported net sales change, as compared to the prior-year period, are shown in the table below.
| Three Months Ended October 1, 2022 | Nine Months Ended October 1, 2022 | ||||||||||
| Reported net sales change | 12 | % | 13 | % | |||||||
| Foreign currency translation | 7 | 5 | |||||||||
Sales change ex. currency(1) | 19 | 18 | |||||||||
| Acquisitions | (4) | (5) | |||||||||
Organic sales change(1) | 16 | % | 13 | % | |||||||
(1) Totals may not sum due to rounding
In the three and nine months ended October 1, 2022, net sales increased on an organic basis compared to the same period in the prior year primarily due to pricing actions.
Net Income
Net income increased from approximately $557 million in the first nine months of 2021 to approximately $634 million in the first nine months of 2022. Major factors affecting the change in net income included the following:
•Net benefit of pricing, freight, energy and raw material costs, including material re-engineering
•Higher income from acquisitions, net of associated amortization of other intangibles
•Lower transaction and related costs
Offsetting factors:
•Unfavorable foreign currency translation
•Higher employee-related costs
•Growth investments
Acquisitions
During January 2022, we completed our acquisitions of TexTrace AG ("TexTrace"), a Switzerland-based technology developer specializing in custom-made woven and knitted radio-frequency identification ("RFID") products that can be sewn onto or inserted into garments, and Rietveld Serigrafie B.V. and Rietveld Screenprinting Serigrafi Baski Matbaa Tekstil Ithalat Ihracat Sanayi ve Ticaret Limited Sirketi (collectively, "Rietveld"), a Netherlands-based provider of external embellishment solutions and application and printing methods for performance brands and team sports in Europe. These acquisitions expand the product portfolio in our Retail Branding and Information Solutions ("RBIS") reportable segment. The acquisitions of TexTrace and Rietveld are referred to collectively as the "2022 Acquisitions."
The aggregate purchase consideration for the 2022 Acquisitions was approximately $35 million. We funded the 2022 Acquisitions using cash and commercial paper borrowings. In addition to the cash paid at closing, the sellers in one of these acquisitions are eligible for earn-out payments of up to $30 million, subject to the acquired company achieving certain post-acquisition performance targets. As of the acquisition date, we included an estimate of the fair value of these earn-out payments in the aggregate purchase consideration.
The 2022 Acquisitions were not material, individually or in the aggregate, to the unaudited Condensed Consolidated Financial Statements.
Refer to Note 2, “Acquisitions,” to the unaudited Condensed Consolidated Financial Statements for more information.
Cost Reduction Actions
2019/2020 Actions
During the nine months ended October 1, 2022, we recorded $8.8 million in restructuring charges related to our 2019/2020 actions. These charges consisted of severance and related costs for the reduction of approximately 430 positions at numerous locations across our company. These actions, which were primarily taken in our RBIS reportable segment, largely related to global headcount and footprint reductions. Accruals for severance and related costs, as well as lease cancellation costs, were not material as of October 1, 2022.
18
Avery Dennison Corporation
Restructuring charges were included in “Other expense (income), net” in the unaudited Condensed Consolidated Statements of Income. Refer to Note 5, “Cost Reduction Actions,” to the unaudited Condensed Consolidated Financial Statements for more information.
Cash Flow
| Nine Months Ended | |||||||||||
| (In millions) | October 1, 2022 | October 2, 2021 | |||||||||
| Net cash provided by operating activities | $ | 615.2 | $ | 762.8 | |||||||
| Purchases of property, plant and equipment | (183.2) | (130.6) | |||||||||
| Purchases of software and other deferred charges | (13.9) | (9.8) | |||||||||
| Proceeds from sales of property, plant and equipment | 2.2 | 1.1 | |||||||||
| Proceeds from insurance and sales (purchases) of investments, net | 1.9 | 1.2 | |||||||||
| Payments for certain acquisition-related transaction costs | .6 | 14.5 | |||||||||
| Free cash flow | $ | 422.8 | $ | 639.2 | |||||||
During the first nine months of 2022, net cash provided by operating activities decreased compared to the same period last year primarily due to changes in operational working capital, higher incentive compensation payments and the timing of payroll payments, partially offset by higher net income and lower tax payments. During the first nine months of 2022, free cash flow decreased compared to the same period last year primarily due to a decrease in net cash provided by operating activities and an increase in purchases of property, plant and equipment.
Outlook
Certain factors that we believe may contribute to our 2022 results are described below.
•We expect net sales to increase by approximately 10%, which includes a decrease of approximately 6% from the effect of foreign currency translation and an increase of approximately 3% from the effect of acquisitions.
•Based on recent exchange rates, we expect foreign currency translation to decrease our operating income by approximately $77 million.
•We expect our full year effective tax rate to be in the mid-20% range.
•We expect fixed and IT capital expenditures of up to $350 million.
ANALYSIS OF RESULTS OF OPERATIONS FOR THE THIRD QUARTER
Income Before Taxes
Three Months Ended | |||||||||||
| (In millions, except percentages) | October 1, 2022 | October 2, 2021 | |||||||||
| Net sales | $ | 2,317.1 | $ | 2,071.8 | |||||||
| Cost of products sold | 1,697.9 | 1,517.4 | |||||||||
| Gross profit | 619.2 | 554.4 | |||||||||
| Marketing, general and administrative expense | 330.8 | 296.9 | |||||||||
| Other expense (income), net | (3.9) | 16.0 | |||||||||
| Interest expense | 21.2 | 18.0 | |||||||||
| Other non-operating expense (income), net | (1.4) | (.9) | |||||||||
| Income before taxes | $ | 272.5 | $ | 224.4 | |||||||
| Gross profit margin | 26.7 | % | 26.8 | % | |||||||
Gross Profit Margin
Gross profit margin for the third quarter of 2022 was relatively unchanged from the same period last year as higher volume/mix primarily related to the impact of acquisitions offset higher employee-related costs.
Marketing, General and Administrative Expense
Marketing, general and administrative expense increased in the third quarter of 2022 compared to the same period last year primarily due to higher employee-related costs, growth investments and the impact of acquisitions, partially offset by the impact of favorable foreign currency translation.
19
Avery Dennison Corporation
Other Expense (Income), Net
| Three Months Ended | |||||||||||
| (In millions) | October 1, 2022 | October 2, 2021 | |||||||||
| Other expense (income), net, by type | |||||||||||
| Restructuring charges: | |||||||||||
| Severance and related costs | $ | 4.7 | $ | 1.1 | |||||||
| Asset impairment charges and lease cancellation costs | .1 | 1.3 | |||||||||
| Other items: | |||||||||||
| Transaction and related costs | — | 19.4 | |||||||||
| Gain on venture investments | (8.7) | (4.9) | |||||||||
| Gain on sale of product line | — | (.9) | |||||||||
| Other expense (income), net | $ | (3.9) | $ | 16.0 | |||||||
Refer to Note 5, “Cost Reduction Actions,” to the unaudited Condensed Consolidated Financial Statements for more information regarding restructuring charges.
Interest Expense
Interest expense increased in the third quarter of 2022 compared to the same period last year primarily as a result of higher interest rates on short-term borrowings and additional interest costs related to the $800 million of senior notes we issued in August 2021.
Net Income and Earnings per Share
Three Months Ended | |||||||||||
| (In millions, except per share amounts and percentages) | October 1, 2022 | October 2, 2021 | |||||||||
| Income before taxes | $ | 272.5 | $ | 224.4 | |||||||
| Provision for income taxes | 51.0 | 59.2 | |||||||||
| Equity method investment (losses) gains | — | (1.1) | |||||||||
| Net income | $ | 221.5 | $ | 164.1 | |||||||
| Per share amounts: | |||||||||||
| Net income per common share | $ | 2.73 | $ | 1.98 | |||||||
| Net income per common share, assuming dilution | 2.70 | 1.96 | |||||||||
| Effective tax rate | 18.7 | % | 26.4 | % | |||||||
Provision for Income Taxes
Our effective tax rate for the three months ended October 1, 2022 decreased compared to the same period last year primarily due to higher discrete benefits related to return-to-provision benefits upon completion of our 2021 U.S. federal tax return, the settlement of certain foreign tax audits, and the benefit from treating a portion of the Brazil indirect tax credit as non-taxable. Refer to Note 7, “Taxes Based on Income,” to the unaudited Condensed Consolidated Financial Statements for more information.
RESULTS OF OPERATIONS BY REPORTABLE SEGMENT FOR THE THIRD QUARTER
Operating income refers to income before taxes, interest and other non-operating expense (income), net.
Label and Graphic Materials
Three Months Ended | |||||||||||
| (In millions) | October 1, 2022 | October 2, 2021 | |||||||||
| Net sales including intersegment sales | $ | 1,540.9 | $ | 1,370.6 | |||||||
| Less intersegment sales | (38.4) | (24.8) | |||||||||
| Net sales | $ | 1,502.5 | $ | 1,345.8 | |||||||
Operating income(1) | 215.6 | 184.9 | |||||||||
(1)Included charges associated with gain on venture investment in 2022, restructuring actions in both years and transaction and related costs and gain on sale of product line in 2021. | $ | (8.0) | $ | .2 | |||||||
20
Avery Dennison Corporation
Net Sales
The factors impacting reported net sales change are shown in the table below.
| Three Months Ended | |||||
| October 1, 2022 | |||||
Reported net sales change | 12 | % | |||
| Foreign currency translation | 8 | ||||
Sales change ex. currency(1) | 20 | ||||
Organic sales change(1) | 20 | % | |||
(1) Totals may not sum due to rounding | |||||
In the third quarter of 2022, net sales increased on an organic basis compared to the same period in the prior year primarily due to pricing actions. On an organic basis, net sales increased by a high-teens rate in emerging markets, a mid-teens rate in North America and approximately 40% in Western Europe.
Operating Income
Operating income increased in the third quarter of 2022 compared to the same period last year primarily due to the net benefit of pricing, freight, energy and raw material costs, including material re-engineering, partially offset by higher employee-related costs and the impact of unfavorable foreign currency translation.
Retail Branding and Information Solutions
Three Months Ended | |||||||||||
| (In millions) | October 1, 2022 | October 2, 2021 | |||||||||
| Net sales including intersegment sales | $ | 633.2 | $ | 541.1 | |||||||
| Less intersegment sales | (10.1) | (10.4) | |||||||||
| Net sales | $ | 623.1 | $ | 530.7 | |||||||
Operating income(1) | 75.8 | 58.5 | |||||||||
(1)Included charges associated with restructuring actions in both years and transaction and related costs and gain on venture investment in 2021. | $ | 3.4 | $ | 14.6 | |||||||
Net Sales
The factors impacting reported net sales change are shown in the table below.
| Three Months Ended | |||||
| October 1, 2022 | |||||
| Reported net sales change | 17 | % | |||
| Reclassification of sales between segments | (1) | ||||
| Foreign currency translation | 5 | ||||
Sales change ex. currency(1) | 22 | ||||
| Acquisitions | (14) | ||||
Organic sales change(1) | 7 | % | |||
(1) Totals may not sum due to rounding | |||||
In the third quarter of 2022, on an organic basis, sales increased by a high-teens rate in high value categories, which was partially offset by a low-single digit rate decrease in the base business.
Operating Income
Operating income increased in the third quarter of 2022 compared to the same period last year primarily due to the combined benefit of higher organic volume and acquisitions, as well as lower transaction and related costs, partially offset by higher amortization of other intangibles resulting from business acquisitions, growth investments and higher employee-related costs.
21
Avery Dennison Corporation
Industrial and Healthcare Materials
Three Months Ended | |||||||||||
| (In millions) | October 1, 2022 | October 2, 2021 | |||||||||
| Net sales including intersegment sales | $ | 198.1 | $ | 199.0 | |||||||
| Less intersegment sales | (6.6) | (3.7) | |||||||||
| Net sales | $ | 191.5 | $ | 195.3 | |||||||
Operating income(1) | 20.3 | 18.7 | |||||||||
(1) Included charges associated with restructuring actions in both years and transaction and related costs in 2021. | $ | .7 | $ | .7 | |||||||
Net Sales
The factors impacting reported net sales change are shown in the table below.
| Three Months Ended | |||||
| October 1, 2022 | |||||
Reported net sales change | (2) | % | |||
| Foreign currency translation | 6 | ||||
Sales change ex. currency(1) | 4 | ||||
| Acquisitions | 1 | ||||
Organic sales change(1) | 5 | % | |||
(1) Totals may not sum due to rounding | |||||
In the third quarter of 2022, net sales increased on an organic basis compared to the same period in the prior year primarily due to increases by a mid-teens rate in healthcare categories and a mid-to-high single digit rate in industrial categories.
Operating Income
Operating income increased in the third quarter of 2022 compared to the same period last year primarily due to the net benefit of pricing, freight, energy and raw material costs, including material re-engineering, partially offset by lower volume/mix and higher employee-related costs.
ANALYSIS OF RESULTS OF OPERATIONS FOR THE NINE MONTHS YEAR-TO-DATE
Income Before Taxes
| Nine Months Ended | |||||||||||
| (In millions, except percentages) | October 1, 2022 | October 2, 2021 | |||||||||
| Net sales | $ | 7,013.4 | $ | 6,225.1 | |||||||
| Cost of products sold | 5,109.4 | 4,497.4 | |||||||||
| Gross profit | 1,904.0 | 1,727.7 | |||||||||
| Marketing, general and administrative expense | 1,018.5 | 916.2 | |||||||||
| Other expense (income), net | (2.1) | 16.3 | |||||||||
| Interest expense | 61.6 | 50.2 | |||||||||
| Other non-operating expense (income), net | (4.1) | (3.6) | |||||||||
| Income before taxes | $ | 830.1 | $ | 748.6 | |||||||
| Gross profit margin | 27.1 | % | 27.8 | % | |||||||
Gross Profit Margin
Gross profit margin for the first nine months of 2022 decreased from the same period last year primarily due to the net impact of pricing, freight, energy and raw material costs, including material re-engineering, as well as higher employee-related costs, partially offset by higher volume/mix primarily related to the impact of acquisitions.
Marketing, General and Administrative Expense
Marketing, general and administrative expense increased in the first nine months of 2022 compared to the same period last year primarily due to the impact of acquisitions, growth investments and higher employee-related costs, partially offset by the impact of favorable foreign currency translation.
22
Avery Dennison Corporation
Other Expense (Income), Net
| Nine Months Ended | |||||||||||
| (In millions) | October 1, 2022 | October 2, 2021 | |||||||||
| Other expense (income), net, by type | |||||||||||
| Restructuring charges: | |||||||||||
| Severance and related costs | $ | 8.7 | $ | 5.1 | |||||||
| Asset impairment charges and lease cancellation costs | .1 | 1.9 | |||||||||
| Other items: | |||||||||||
| Transaction and related costs | .3 | 20.1 | |||||||||
| Outcomes of legal proceedings, net | 1.7 | (.4) | |||||||||
| Gain on venture investments | (12.4) | (4.9) | |||||||||
| (Gain) loss on sales of assets, net | (.5) | .2 | |||||||||
| Gain on sale of product line | — | (5.7) | |||||||||
| Other expense (income), net | $ | (2.1) | $ | 16.3 | |||||||
Refer to Note 5, “Cost Reduction Actions,” to the unaudited Condensed Consolidated Financial Statements for more information regarding restructuring charges. Refer to Note 12, “Segment and Disaggregated Revenue Information,” to the unaudited Condensed Consolidated Financial Statements for more information regarding outcomes of legal proceedings.
Interest Expense
Interest expense increased in the first nine months of 2022 compared to the same period last year primarily as a result of additional interest costs related to the $800 million of senior notes we issued in August 2021 and higher interest rates on short-term borrowings.
Net Income and Earnings per Share
| Nine Months Ended | |||||||||||
| (In millions, except per share amounts and percentages) | October 1, 2022 | October 2, 2021 | |||||||||
| Income before taxes | $ | 830.1 | $ | 748.6 | |||||||
| Provision for income taxes | 195.9 | 187.7 | |||||||||
| Equity method investment (losses) gains | — | (3.5) | |||||||||
| Net income | $ | 634.2 | $ | 557.4 | |||||||
| Per share amounts: | |||||||||||
| Net income per common share | $ | 7.75 | $ | 6.72 | |||||||
| Net income per common share, assuming dilution | 7.70 | 6.64 | |||||||||
| Effective tax rate | 23.6 | % | 25.1 | % | |||||||
Provision for Income Taxes
Our effective tax rate for the nine months ended October 1, 2022 decreased compared to the same period last year primarily due to higher discrete benefits related to the settlement of certain foreign tax audits and the benefit from treating a portion of the Brazil indirect tax credit as non-taxable, as well as U.S. federal return-to-provision benefits that were lower than in the previous year. Refer to Note 7, “Taxes Based on Income,” to the unaudited Condensed Consolidated Financial Statements for more information.
On August 16, 2022, the U.S. government enacted the Inflation Reduction Act ("IRA"), which, among other things, implements a 15% corporate alternative minimum tax based on the adjusted financial statement income for certain large corporations and a 1% excise tax on net share repurchases. The minimum tax and the excise tax, if applicable, are effective for fiscal years beginning after December 31, 2022. We do not expect the IRA to have a material impact on our financial position, results of operations or cash flows. We will continue to monitor additional guidance from the IRS.
We estimate our effective tax rate for fiscal year 2022 to be in the mid-20% range. Our effective tax rate can vary from quarter to quarter due to a variety of factors, such as changes in the mix of earnings in countries with differing statutory tax rates, changes in tax reserves, settlements of income tax audits, changes in tax laws and regulations, return-to-provision adjustments, tax impacts related to stock-based payments and execution of tax planning strategies.
23
Avery Dennison Corporation
RESULTS OF OPERATIONS BY REPORTABLE SEGMENT FOR THE NINE MONTHS YEAR-TO-DATE
Operating income refers to income before taxes, interest and other non-operating expense (income), net.
Label and Graphic Materials
| Nine Months Ended | |||||||||||
| (In millions) | October 1, 2022 | October 2, 2021 | |||||||||
| Net sales including intersegment sales | $ | 4,571.5 | $ | 4,170.1 | |||||||
| Less intersegment sales | (97.0) | (71.1) | |||||||||
| Net sales | $ | 4,474.5 | $ | 4,099.0 | |||||||
Operating income(1) | 649.1 | 639.2 | |||||||||
(1)Included gain on venture investment in 2022, charges associated with restructuring actions in both years and transaction and related costs, outcomes of legal proceedings and gain on sale of product line in 2021. | $ | (10.7) | $ | (30.2) | |||||||
Net Sales
The factors impacting reported net sales change are shown in the table below.
| Nine Months Ended | |||||
| October 1, 2022 | |||||
| Reported net sales change | 9 | % | |||
| Foreign currency translation | 6 | ||||
Sales change ex. currency(1) | 15 | ||||
Organic sales change(1) | 16 | % | |||
(1) Totals may not sum due to rounding
In the first nine months of 2022, net sales increased on an organic basis compared to the same period in the prior year due to pricing actions, partially offset by lower volume/mix. On an organic basis, net sales increased by a low-double digit rate in emerging markets, a high-teens rate in North America and over 20% in Western Europe.
Operating Income
Operating income increased in the first nine months of 2022 compared to the same period last year primarily due to the net benefit of pricing, freight, energy and raw material costs, including material re-engineering, partially offset by the impact of unfavorable foreign currency translation, higher employee-related costs and the impact of the Brazilian indirect tax credit in the prior year.
Retail Branding and Information Solutions
| Nine Months Ended | |||||||||||
| (In millions) | October 1, 2022 | October 2, 2021 | |||||||||
| Net sales including intersegment sales | $ | 1,988.8 | $ | 1,570.8 | |||||||
| Less intersegment sales | (29.2) | (28.1) | |||||||||
| Net sales | $ | 1,959.6 | $ | 1,542.7 | |||||||
Operating income(1) | 250.7 | 160.6 | |||||||||
(1) Included charges associated with restructuring actions, outcome of legal proceedings, transaction and related costs and (gain) loss on sale of assets in both years and gain on venture investment in 2021. | $ | 6.3 | $ | 44.2 | |||||||
24
Avery Dennison Corporation
Net Sales
The factors impacting reported net sales change are shown in the table below.
| Nine Months Ended | |||||
| October 1, 2022 | |||||
| Reported net sales change | 27 | % | |||
| Reclassification of sales between segments | (1) | ||||
| Foreign currency translation | 4 | ||||
Sales change ex. currency(1) | 30 | ||||
| Acquisitions | (20) | ||||
Organic sales change(1) | 10 | % | |||
(1)Totals may not sum due to rounding
In the first nine months of 2022, on an organic basis, sales increased by roughly 20% in high value categories and a low-to-mid-single digit rate in the base business.
Company-wide, on an organic basis, sales of Intelligent Label solutions increased by roughly 20%.
Operating Income
Operating income increased in the first nine months of 2022 compared to the same period last year primarily due to the combined benefit of higher organic volume and acquisitions, the impact of the outcome of legal proceedings in the prior year, as well as lower transaction and related costs, partially offset by higher amortization of other intangibles resulting from business acquisitions, growth investments and employee-related costs.
Industrial and Healthcare Materials
| Nine Months Ended | |||||||||||
| (In millions) | October 1, 2022 | October 2, 2021 | |||||||||
| Net sales including intersegment sales | $ | 595.7 | $ | 591.4 | |||||||
| Less intersegment sales | (16.4) | (8.0) | |||||||||
| Net sales | $ | 579.3 | $ | 583.4 | |||||||
Operating income(1) | 56.3 | 64.7 | |||||||||
(1) Included charges associated with restructuring actions in both years and transaction and related costs and gain on sale of assets in 2021. | $ | .8 | $ | 1.3 | |||||||
Net Sales
The factors impacting reported net sales change are shown in the table below.
| Nine Months Ended | |||||
| October 1, 2022 | |||||
| Reported net sales change | (1) | % | |||
| Foreign currency translation | 4 | ||||
Sales change ex. currency(1) | 3 | ||||
| Acquisitions | 1 | ||||
Organic sales change(1) | 4 | % | |||
(1) Totals may not sum due to rounding
In the first nine months of 2022, net sales increased on an organic basis compared to the same period in the prior year primarily due to increases by a mid-teens rate in healthcare categories and a low-to-mid single digit rate in industrial categories.
Operating Income
Operating income decreased in the first nine months of 2022 compared to the same period last year primarily due to lower volume/mix and higher employee-related costs, partially offset by the net benefit of pricing, freight, energy and raw material costs, including material re-engineering.
25
Avery Dennison Corporation
FINANCIAL CONDITION
Liquidity
Operating Activities
| Nine months ended | |||||||||||
| (In millions) | October 1, 2022 | October 2, 2021 | |||||||||
| Net income | $ | 634.2 | $ | 557.4 | |||||||
| Depreciation | 132.2 | 122.9 | |||||||||
| Amortization | 85.0 | 48.6 | |||||||||
| Provision for credit losses and sales returns | 36.9 | 26.1 | |||||||||
| Stock-based compensation | 34.5 | 27.1 | |||||||||
| Pension plan settlement loss | — | 1.0 | |||||||||
| Deferred taxes and other non-cash taxes | (8.5) | (1.5) | |||||||||
| Other non-cash expense and loss (income and gain), net | 14.7 | 17.7 | |||||||||
| Changes in assets and liabilities and other adjustments | (313.8) | (36.5) | |||||||||
| Net cash provided by operating activities | $ | 615.2 | $ | 762.8 | |||||||
During the first nine months of 2022, net cash provided by operating activities decreased compared to the same period last year primarily due to changes in operational working capital, higher incentive compensation payments and the timing of payroll payments, partially offset by higher net income and lower tax payments.
Investing Activities
| Nine months ended | |||||||||||
(In millions) | October 1, 2022 | October 2, 2021 | |||||||||
| Purchases of property, plant and equipment | $ | (183.2) | $ | (130.6) | |||||||
| Purchases of software and other deferred charges | (13.9) | (9.8) | |||||||||
| Proceeds from sales of property, plant and equipment | 2.2 | 1.1 | |||||||||
| Proceeds from insurance and sales (purchases) of investments, net | 1.9 | 1.2 | |||||||||
| Proceeds from sale of product line | — | 6.7 | |||||||||
| Payments for acquisitions, net of cash acquired, and investments in businesses | (37.0) | (1,474.3) | |||||||||
| Net cash used in investing activities | $ | (230.0) | $ | (1,605.7) | |||||||
Purchases of Property, Plant and Equipment
During the first nine months of 2022, we primarily invested in buildings and equipment to support growth in certain countries in Asia and the U.S. for our RBIS reportable segment, in certain countries in Europe, the U.S. and certain countries in Latin America for our Labels and Graphic Materials (“LGM”) reportable segment, and in the U.S. for our Industrial and Healthcare Materials ("IHM") reportable segment. During the first nine months of 2021, we primarily invested in equipment to support growth in the U.S. and certain countries in Europe and Asia for our LGM reportable segment, in certain countries in Asia for our RBIS reportable segment, and in the U.S. for our IHM reportable segment.
Purchases of Software and Other Deferred Charges
During the first nine months of 2022, we primarily invested in information technology upgrades in the U.S. and Asia. During the first nine months of 2021, we primarily invested in information technology upgrades in the U.S. and Europe.
Proceeds from Sale of Product Line
During the first nine months of 2021, we received proceeds from the sale of a product line in our LGM reportable segment.
Payments for Acquisitions, Net of Cash Acquired, and Investments in Businesses
During the first nine months of 2022, we paid consideration, net of cash acquired, of approximately $30 million for the 2022 Acquisitions. We funded the 2022 Acquisitions using cash and commercial paper borrowings. During the first nine months of 2021, we paid consideration, net of cash acquired, of approximately $1.44 billion and $32 million for the CB Velocity Holdings, LLC (“Vestcom”) acquisition and other acquisitions, respectively. We funded the Vestcom acquisition using the net proceeds from the senior notes we issued in August 2021, commercial paper borrowings and cash. Our other acquisitions in 2021 were funded using cash and commercial paper borrowings. We also made certain venture investments in the first nine months of both 2022 and 2021.
26
Avery Dennison Corporation
Financing Activities
| Nine months ended | |||||||||||
(In millions) | October 1, 2022 | October 2, 2021 | |||||||||
| Net increase (decrease) in borrowings with maturities of three months or less | $ | 115.9 | $ | 332.0 | |||||||
| Additional long-term borrowings | — | 791.9 | |||||||||
| Repayments of long-term debt and finance leases | (4.4) | (8.0) | |||||||||
| Dividends paid | (178.3) | (164.3) | |||||||||
| Share repurchases | (318.6) | (126.0) | |||||||||
| Net (tax withholding) proceeds related to stock-based compensation | (25.1) | (25.5) | |||||||||
Net cash (used in) provided by financing activities | $ | (410.5) | $ | 800.1 | |||||||
Borrowings and Repayment of Debt
During the first nine months of 2022 and 2021, our commercial paper borrowings were used to fund acquisitions, dividend payments, share repurchases, capital expenditures and other general corporate purposes.
In August 2021, we issued $500 million of senior notes, due February 15, 2032, which bear an interest rate of 2.250%, payable semiannually in arrears. Our net proceeds from this issuance, after deducting underwriting discounts and offering expenses, were $493.8 million. Additionally, in August 2021, we issued $300 million of senior notes, due August 15, 2024, which we can repay without penalty and bear an interest rate of 0.850%, payable semiannually in arrears. Our net proceeds from this issuance, after deducting underwriting discounts and offering expenses, were $298.1 million. We used the net proceeds from these two debt issuances to finance a portion of the Vestcom acquisition.
Refer to Note 2, “Acquisitions,” and Note 4, “Debt,” to the unaudited Condensed Consolidated Financial Statements for more information.
Dividends Paid
We paid dividends of $2.18 per share in the first nine months of 2022 compared to $1.98 per share in the same period last year. In April 2022, we increased our quarterly dividend rate to $.75 per share, representing an increase of approximately 10% from our previous quarterly dividend rate of $.68 per share.
Share Repurchases
During the first nine months of 2022 and 2021, we repurchased approximately 1.8 million and 0.7 million shares of our common stock, respectively.
In April 2022, our Board authorized the repurchase of shares of our common stock with a fair market value of up to $750 million, excluding any fees, commissions or other expenses related to such purchases and in addition to the amount outstanding under our previous Board authorization. Board authorizations remain in effect until shares in the amount authorized thereunder have been repurchased. As of October 1, 2022, shares of our common stock in the aggregate amount of $791 million remained authorized for repurchase under our outstanding Board authorizations.
Analysis of Selected Balance Sheet Accounts
Long-lived Assets
In the nine months ended October 1, 2022, goodwill decreased by approximately $57 million to $1.82 billion, reflecting the impact of foreign currency translation, partially offset by the preliminary goodwill associated with the 2022 Acquisitions.
In the nine months ended October 1, 2022, other intangibles resulting from business acquisitions, net, decreased by approximately $56 million to $855.1 million, reflecting current year amortization expense and the impact of foreign currency translation, partially offset by the preliminary valuation of intangible assets associated with the 2022 Acquisitions.
Refer to Note 3, “Goodwill and Other Intangibles Resulting from Business Acquisitions,” to the unaudited Condensed Consolidated Financial Statements for more information.
Shareholders’ Equity Accounts
As of October 1, 2022, the balance of our shareholders’ equity was $2.01 billion. Refer to Note 9, “Supplemental Equity and Comprehensive Income Information,” to the unaudited Condensed Consolidated Financial Statements for more information.
27
Avery Dennison Corporation
Impact of Foreign Currency Translation
| Nine Months Ended | |||||
| (In millions) | October 1, 2022 | ||||
| Change in net sales | $ | (275) | |||
International operations generated approximately 72% of our net sales during the nine months ended October 1, 2022. Our future results are subject to changes in political and economic conditions globally and in the regions in which we operate and the impact of fluctuations in foreign currency exchange and interest rates.
The unfavorable impact of foreign currency translation on net sales in the first nine months of 2022 compared to the same period last year was primarily related to euro-denominated sales.
Effect of Foreign Currency Transactions
The impact on net income from transactions denominated in foreign currencies is largely mitigated because the costs of our products are generally denominated in the same currencies in which they are sold. In addition, to reduce our income and cash flow exposure to transactions in foreign currencies, we enter into foreign exchange forward, option and swap contracts where available and appropriate. Refer to Note 6, “Financial Instruments,” to the unaudited Condensed Consolidated Financial Statements for more information.
Analysis of Selected Financial Ratios
We utilize the financial ratios discussed below to assess our financial condition and operating performance. We believe this information assists our investors in understanding the factors impacting our cash flow other than net income and capital expenditures.
Operational Working Capital Ratio
Operational working capital, as a percentage of annualized current-quarter net sales, is reconciled to working capital below. Our objective is to minimize our investment in operational working capital, as a percentage of annualized current-quarter net sales, to maximize cash flow and return on investment. Operational working capital, as a percentage of annualized current-quarter net sales, in the third quarter of 2022 was higher compared to the third quarter of 2021.
| (In millions, except percentages) | October 1, 2022 | October 2, 2021 | |||||||||
| (A) Working capital | $ | 22.5 | $ | 169.1 | |||||||
| Reconciling items: | |||||||||||
| Cash and cash equivalents | (128.2) | (207.2) | |||||||||
| Other current assets | (233.6) | (251.0) | |||||||||
| Short-term borrowings and current portion of long-term debt and finance leases | 669.9 | 398.8 | |||||||||
| Accrued payroll and employee benefits and other current liabilities | 886.3 | 942.4 | |||||||||
| (B) Operational working capital | $ | 1,216.9 | $ | 1,052.1 | |||||||
(C) Third-quarter net sales, annualized(1) | $ | 9,268.4 | $ | 8,523.4 | |||||||
| Operational working capital, as a percentage of annualized current-quarter net sales: (B) ÷ (C) | 13.1 | % | 12.3 | % | |||||||
(1) Included estimated 2021 annualized sales for Vestcom
Accounts Receivable Ratio
The average number of days sales outstanding was 62 days in both the third quarter of 2022 and 2021, calculated using the accounts receivable balance at quarter-end divided by the average daily sales in the respective quarter. The third quarter of 2021 included estimated sales for Vestcom.
Inventory Ratio
Average inventory turnover was 6.7 in the third quarter of 2022 compared to 7.1 in the third quarter of 2021, calculated using the annualized third-quarter cost of products sold in 2022 and 2021, respectively, and divided by the inventory balance at quarter-end. The third quarter of 2021 included estimated cost of products sold for Vestcom. The decrease in average inventory turnover primarily reflected increased inventory to manage through supply chain constraints.
Accounts Payable Ratio
The average number of days payable outstanding was 74 days in both the third quarter of 2022 and 2021, calculated using the accounts payable balance at quarter-end divided by the respective annualized third-quarter cost of products sold. The third quarter of 2021 included estimated cost of products sold for Vestcom.
28
Avery Dennison Corporation
Capital Resources
Capital resources include cash flows from operations, cash and cash equivalents and debt financing, including access to commercial paper borrowings supported by our $800 million revolving credit facility (the “Revolver”). We use these resources to fund our operational needs.
As of October 1, 2022, we had cash and cash equivalents of $128.2 million held in accounts at third-party financial institutions. Our cash balances are held in numerous locations throughout the world. As of October 1, 2022, the majority of our cash and cash equivalents was held by our foreign subsidiaries, primarily in the Asia Pacific region.
To meet our U.S. cash requirements, we have several cost-effective liquidity options available. These options include borrowing funds at reasonable rates, including borrowings from foreign subsidiaries, and repatriating foreign earnings and profits. However, if we were to repatriate foreign earnings and profits, a portion would be subject to cash payments of withholding taxes imposed by foreign tax authorities. Additional U.S. taxes may also result from the impact of foreign currency fluctuations related to these earnings and profits.
The Revolver, which matures in February 2025, is used as a back-up facility for our commercial paper borrowings and can be used for other corporate purposes. No balance was outstanding under the Revolver as of October 1, 2022 or January 1, 2022.
We currently anticipate using cash flows from operations and commercial paper borrowings to repay approximately $250 million of senior notes maturing in the second quarter of 2023.
Capital from Debt
The carrying value of our total debt increased by approximately $28 million in the first nine months of 2022 to $3.13 billion, primarily reflecting a net increase in commercial paper borrowings, partially offset by the revaluation of our euro-denominated senior notes, due in 2025.
Credit ratings are a significant factor in our ability to raise short- and long-term financing. The credit ratings assigned to us also impact the interest rates we pay and our access to commercial paper, credit facilities and other borrowings. A downgrade of our short-term credit ratings could impact our ability to access commercial paper markets. If our access to commercial paper markets were to become limited, we believe that the Revolver and our other credit facilities would be available to meet our short-term funding requirements. When determining a credit rating, we believe that rating agencies primarily consider our competitive position, business outlook, consistency of cash flows, debt level and liquidity, geographic dispersion and management team. We remain committed to maintaining an investment grade rating.
Off-Balance Sheet Arrangements, Contractual Obligations, and Other Matters
As of October 1, 2022, we have a commitment to purchase approximately $220 million of raw materials in fiscal year 2023. Additionally, in October 2022, subsequent to the end of the third quarter of 2022, we entered into a separate commitment to purchase approximately $70 million of raw materials in the first half of 2023.
Refer to Note 11, “Commitments and Contingencies,” to the unaudited Condensed Consolidated Financial Statements for further information. Except as indicated therein, we have no material off-balance sheet arrangements as described in Item 303(b) of Regulation S-K.
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
There have been no material changes to the information provided in Part II, Item 7A of our Annual Report on Form 10-K for the fiscal year ended January 1, 2022 that have not been disclosed in our periodic filings with the U.S. Securities and Exchange Commission (SEC).
29
Avery Dennison Corporation
ITEM 4. CONTROLS AND PROCEDURES
Evaluation of Disclosure Controls and Procedures
We maintain disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(f)) that are designed to ensure that information required to be disclosed in our Exchange Act reports is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding the required disclosure.
In designing and evaluating the disclosure controls and procedures, we recognize that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management necessarily is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.
Our disclosure controls system is based upon a global chain of financial and general business reporting lines that converge in our headquarters in Mentor, Ohio. As required by SEC Rule 13a-15(b), we carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the quarter covered by this report. Based on the foregoing, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures were effective as of such time to provide reasonable assurance that information was recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information was accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding the required disclosure.
Changes in Internal Control Over Financial Reporting
There were no changes in our internal control over financial reporting during the most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
30
Avery Dennison Corporation
PART II. OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS
Refer to “Legal Proceedings” in Note 11, “Commitments and Contingencies,” to the unaudited Condensed Consolidated Financial Statements in Part 1, Item 1 for this information.
ITEM 1A. RISK FACTORS
There have been no material changes to the risk factors included in Part I, Item 1A, of our Annual Report on Form 10-K for the fiscal year ended January 1, 2022 that have not been disclosed in our periodic filings with the SEC, except as set forth below.
The demand for our products is impacted by the effects of, and changes in, worldwide economic, social, political and market conditions, which could have a material adverse effect on our business.
We have operations in over 50 countries and our domestic and international operations are strongly influenced by matters beyond our control, including changes in political, social, economic and labor conditions, tax laws (including U.S. taxes on foreign earnings), and international trade regulations (including tariffs), as well as the impact of these changes on the underlying demand for our products. In 2021, approximately 75% of our net sales were from international operations.
Macroeconomic developments such as impacts from COVID-19, inflation, raw material, freight and labor availability, slower growth in the geographic regions in which we operate and uncertainty in the global credit or financial markets leading to a loss of consumer confidence could result in a material adverse effect on our business as a result of, among other things, reduced consumer spending, declines in asset valuations, diminished liquidity and credit availability, volatility in securities prices, credit rating downgrades and fluctuations in foreign currency exchange rates.
We continue to face uncertainty from relations between the U.S. and China. Over the past few years, the U.S. government has imposed additional tariffs on products imported into the U.S. from China. This has resulted in reciprocal tariffs on goods imported from the U.S. into China. The impacts on our operations to date have not been significant. There remains risk that our business could be significantly impacted if additional tariffs or other restrictions are imposed on products. Any of these actions or further developments in international trade relations could have a material adverse effect on our business.
In addition, business and operational disruptions or delays caused by political, social or economic instability and unrest – such as civil, political and economic disturbances in places such as the U.S., Russia, Ukraine, Afghanistan, Syria, Iraq, Iran, Turkey, North Korea, Hong Kong and Sri Lanka and the related impact on global stability, terrorist attacks and the potential for other hostilities, public health crises or natural disasters in various parts of the world – could contribute to a climate of economic and political uncertainty that in turn could have a material adverse effect on our business. In February 2022, Russia invaded Ukraine resulting in the U.S., Canada, the European Union and other countries imposing economic sanctions on Russia. Additional potential sanctions and penalties have been proposed or threatened. Russian military actions and the resulting sanctions could adversely affect the global economy and financial markets. Any Russian response could also disrupt commercial and financial transactions. We have ceased shipment of all products for the Russian market. Our sales for the Russian market were approximately 1% of our net sales in 2021. Further, the continuing conflict in Ukraine has spilled over into neighboring countries due to the displacement of a large number of refugees, which could adversely impact the global supply chain and disrupt our operations or negatively impact the demand for our products in our primary end markets. Any such disruption could have a material adverse effect to our financial results.
We are not able to predict the duration and severity of adverse economic, social, political or market conditions in the U.S. or other countries.
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
(a)Not Applicable
(b)Not Applicable
(c)Repurchases of Equity Securities by Issuer
31
Avery Dennison Corporation
Repurchases by us or our “affiliated purchasers” (as defined in Rule 10b-18(a)(3) of the Exchange Act) of registered equity securities in the third quarter of 2022 are shown in the table below. Repurchased shares may be reissued under our long-term incentive plan or used for other corporate purposes.
Period(1) | Total number of shares purchased(2) | Average price paid per share | Total number of shares purchased as part of publicly announced plans(2)(3) | Approximate dollar value of shares that may yet be purchased under the plans(4) | |||||||||||||||||||
| July 3, 2022 – July 30, 2022 | 126.7 | $ | 167.21 | 126.7 | $ | 819.7 | |||||||||||||||||
| July 31, 2022 – August 27, 2022 | 35.4 | 192.80 | 35.4 | 812.9 | |||||||||||||||||||
| August 28, 2022 – October 1, 2022 | 123.9 | 176.45 | 123.9 | 791.0 | |||||||||||||||||||
| Total | 286.0 | $ | 174.38 | 286.0 | $ | 791.0 | |||||||||||||||||
(1)The periods shown are our fiscal periods during the thirteen-week quarter ended October 1, 2022.
(2)Shares in thousands.
(3)In April 2019, our Board authorized the repurchase of shares of our common stock with a fair market value of up to $650 million, excluding any fees, commissions or other expenses related to such purchases. In April 2022, our Board authorized the repurchase of shares of our common stock with a fair market value of up to $750 million, excluding any fees, commissions or other expenses related to such purchases, in addition to the amount outstanding under our previous Board authorization. Board authorizations remain in effect until shares in the amount authorized thereunder have been repurchased..
(4)Dollars in millions.
ITEM 3. DEFAULTS UPON SENIOR SECURITIES
Not Applicable
ITEM 4. MINE SAFETY DISCLOSURES
Not Applicable
ITEM 5. OTHER INFORMATION
Not Applicable
ITEM 6. EXHIBITS
| Exhibit 31.1* | |||||
| Exhibit 31.2* | |||||
| Exhibit 32.1** | |||||
| Exhibit 32.2** | |||||
| Exhibit 101.INS*** | Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. | ||||
| Exhibit 101.SCH*** | Inline XBRL Extension Schema Document | ||||
| Exhibit 101.CAL*** | Inline XBRL Extension Calculation Linkbase Document | ||||
| Exhibit 101.LAB*** | Inline XBRL Extension Label Linkbase Document | ||||
| Exhibit 101.PRE*** | Inline XBRL Extension Presentation Linkbase Document | ||||
| Exhibit 101.DEF*** | Inline XBRL Extension Definition Linkbase Document | ||||
| Exhibit 104*** | Inline XBRL for the cover page of this Quarterly Report on Form 10-Q, included as part of this Exhibit 101 Inline XBRL document set | ||||
____________________
| * | Filed herewith. | ||||
| ** | Furnished herewith. | ||||
| *** | Furnished herewith. Pursuant to Rule 406T of Regulation S-T, the Interactive Data Files on Exhibit 101 hereto are deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act, are deemed not filed for purposes of Section 18 of the Exchange Act and otherwise are not subject to liability under those sections. | ||||
32
Avery Dennison Corporation
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| AVERY DENNISON CORPORATION | |||||
| (Registrant) | |||||
| /s/ Gregory S. Lovins | |||||
| Gregory S. Lovins | |||||
| Senior Vice President and Chief Financial Officer | |||||
| (Principal Financial Officer) | |||||
| /s/ Lori J. Bondar | |||||
| Lori J. Bondar | |||||
| Vice President, Controller, Treasurer, and Chief Accounting Officer | |||||
| (Principal Accounting Officer) | |||||
November 1, 2022 | |||||
33
Avery Dennison Corporation
Exhibit 31.1
CERTIFICATION OF CHIEF EXECUTIVE OFFICER
PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
CERTIFICATION
I, Mitchell R. Butier, certify that:
1.I have reviewed this Quarterly Report on Form 10-Q of Avery Dennison Corporation;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a)designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d)disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a)all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b)any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
| /s/ | Mitchell R. Butier | |||||||
| Mitchell R. Butier Chairman and Chief Executive Officer | ||||||||
November 1, 2022 | ||||||||
Avery Dennison Corporation
Exhibit 31.2
CERTIFICATION OF CHIEF FINANCIAL OFFICER
PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
CERTIFICATION
I, Gregory S. Lovins, certify that:
1.I have reviewed this Quarterly Report on Form 10-Q of Avery Dennison Corporation;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a)designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d)disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a)all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b)any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
| /s/ | Gregory S. Lovins | |||||||
| Gregory S. Lovins Senior Vice President and Chief Financial Officer | ||||||||
November 1, 2022 | ||||||||
Avery Dennison Corporation
Exhibit 32.1
CERTIFICATION OF CHIEF EXECUTIVE OFFICER*
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
Pursuant to 18 U.S.C. Section 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of Avery Dennison Corporation (the “Company”) hereby certifies, to the best of his knowledge, that:
(i)the Quarterly Report on Form 10-Q of the Company for the fiscal quarter ended October 1, 2022 (the “Report”) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and
(ii)the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Dated: November 1, 2022 | ||||||||
| /s/ | Mitchell R. Butier | |||||||
| Mitchell R. Butier Chairman and Chief Executive Officer | ||||||||
*The above certification accompanies the Company’s Quarterly Report on Form 10-Q and is furnished, not filed, as provided in SEC Release 33-8238, dated June 5, 2003.
Avery Dennison Corporation
Exhibit 32.2
CERTIFICATION OF CHIEF FINANCIAL OFFICER*
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
Pursuant to 18 U.S.C. Section 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of Avery Dennison Corporation (the “Company”) hereby certifies, to the best of his knowledge, that:
(i)the Quarterly Report on Form 10-Q of the Company for the fiscal quarter ended October 1, 2022 (the “Report”) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and
(ii)the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Dated: November 1, 2022 | ||||||||
| /s/ | Gregory S. Lovins | |||||||
| Gregory S. Lovins Senior Vice President and Chief Financial Officer | ||||||||
*The above certification accompanies the Company’s Quarterly Report on Form 10-Q and is furnished, not filed, as provided in SEC Release 33-8238, dated June 5, 2003.